Sv Well And Care Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 15.34%
- Profit Growth -13.09%
- Ebitda 96.96%
- Net Worth 30.24%
- Total Assets 57.73%
About Sv Well And Care Pharmaceuticals
Sv Well And Care Pharmaceuticals Private Limited (SWACPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 April 2012 and has a history of 12 years and nine months. Its registered office is in Dehradun, Uttarakhand, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Varun Bharti and Ankur Bharti serve as directors at the Company.
Company Details
-
Location
Dehradun, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100UR2012PTC000231
-
Company No.
000231
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Apr 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Sv Well And Care Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Bharti
|
Director | 24-Apr-2012 | Current |
|
Ankur Bharti
|
Director | 05-Oct-2017 | Current |
Financial Performance of Sv Well And Care Pharmaceuticals.
Sv Well And Care Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 15.34% increase. The company also saw a substantial fall in profitability, with a 13.09% decrease in profit. The company's net worth Soared by an impressive increase of 30.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sv Well And Care Pharmaceuticals?
In 2017, Sv Well And Care Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cardion Biotech Private LimitedVarun Bharti is a mutual person
-
Alvaro Biotech Private Limited
Varun Bharti is a mutual person
-
Shri Durga Infraventures Llp
Ankur Bharti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sv Well And Care Pharmaceuticals?
Unlock and access historical data on people associated with Sv Well And Care Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sv Well And Care Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sv Well And Care Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
